Our studies of tumor specimens from patients with GBM further demonstrated that high tumor expression of COX4-1 correlates in a significant manner with poor patient prognosis, whereas high COX4-2 expression does not, suggesting novel functions for these COX4 isoforms [16]. This evidence concerns the gene COX4I2 and glioblastoma.